Seiji Shigekawa
Overview
Explore the profile of Seiji Shigekawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
109
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hypoxia-Regulated CD44 and xCT Expression Contributes to Late Postoperative Epilepsy in Glioblastoma
Kusakabe K, Inoue A, Ohnishi T, Nakamura Y, Ohtsuka Y, Nishikawa M, et al.
Biomedicines
. 2025 Feb;
13(2).
PMID: 40002787
Background/objectives: Late epilepsy occurring in the late stage after glioblastoma (GBM) resection is suggested to be caused by increased extracellular glutamate (Glu). To elucidate the mechanism underlying postoperative late epilepsy,...
2.
Inoue A, Watanabe H, Kusakabe K, Nishikawa M, Ohtsuka S, Shiraishi Y, et al.
Acta Neurochir (Wien)
. 2025 Feb;
167(1):49.
PMID: 39969596
Background: Amide proton transfer (APT) imaging has been proposed as a technique to assess tumor metabolic activity. We have previously C-methionine positron emission tomography (C-Met-PET) can evaluate the metabolic activity...
3.
Inagaki R, Kohno D, Shigekawa S, Inoue A, Kitazawa R, Kunieda T
Surg Neurol Int
. 2025 Feb;
16:28.
PMID: 39926464
Background: Granular cell tumors (GCTs) are rare, usually benign, tumors with classic histomorphology. This tumor can occur throughout the body, but the spine is a distinctly rare location. Here, we...
4.
Fujishita S, Inoue A, Watanabe H, Nishikawa M, Taniwaki M, Matsumoto S, et al.
Surg Neurol Int
. 2024 Oct;
15:330.
PMID: 39372983
Background: Cryptococcal infections of the central nervous system are infrequent in immunocompetent hosts and usually present as meningitis. However, a fungal mass called a cryptococcoma may form, requiring caution in...
5.
Inoue A, Miyazaki Y, Watanabe H, Nishikawa M, Kusakabe K, Ohnishi T, et al.
Acta Neurol Belg
. 2024 Sep;
125(1):99-108.
PMID: 39306596
Background: Primary central nervous system lymphoma (PCNSL) is a rapidly growing malignant tumor that typically shows sensitivity to high-dose methotrexate-based chemotherapy. Rapid diagnosis and early chemotherapy are thus essential to...
6.
Shigekawa S, Inoue A, Endo T, Muto J, Inoue T, Kanematsu R, et al.
J Neurosurg Spine
. 2024 Sep;
41(6):699-707.
PMID: 39303310
Objective: Primary spinal cord gliomas are rare, and among these astrocytomas (WHO grade II) are much rarer. The optimal treatment strategy thus remains unclear. The authors conducted a multicenter study...
7.
Shigekawa S, Inoue A, Miyazaki Y, Taniwaki M, Kanehisa K, Matsumoto S, et al.
Surg Neurol Int
. 2024 Mar;
15:41.
PMID: 38468650
Background: Primary intramedullary spinal cord lymphoma (PISCL) is an extremely rare condition. Early diagnosis is very difficult due to the nonspecific clinical and imaging findings. A biopsy is essential for...
8.
Inoue T, Endo T, Muto J, Umebayashi D, Mitsuhara T, Shigekawa S, et al.
J Neurosurg Spine
. 2023 Nov;
40(2):196-205.
PMID: 37976504
Objective: Cancers in adolescents and young adults (AYAs) (age 15-39 years) often present with unique characteristics and poor outcomes. To date, spinal cord glioblastoma, a rare tumor, remains poorly understood...
9.
Inoue A, Watanabe H, Kusakabe K, Nishikawa M, Shiraishi Y, Taniwaki M, et al.
Neurosurg Rev
. 2023 Nov;
46(1):294.
PMID: 37925381
Background: Amide proton transfer (APT) imaging has been proposed as a technique to assess tumor metabolism. However, the relationship between APT imaging and other quantitative modalities including positron emission tomography...
10.
Muto J, Murata H, Shigekawa S, Mitsuhara T, Umebayashi D, Kanematsu R, et al.
Neurospine
. 2023 Oct;
20(3):774-782.
PMID: 37798969
Objective: The characteristics, imaging features, long-term surgical outcomes, and recurrence rates of primary spinal pilocytic astrocytomas (PAs) have not been clarified owing to their rarity and limited reports. Thus, this...